PACB Pacific Biosciences of California Inc.

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).

The call will be webcast and may be accessed on PacBio’s website at .

Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)

Listen live via internet or replay:

Toll-free: 1-888-349-0136

International: 1-412-317-0459

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit  and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:

Media:



EN
16/04/2026

Underlying

PACBPacific Biosciences of California Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pacific Biosciences of California Inc.

 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio’s website at . Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Listen live via internet or replay: Toll-free: 1-888-349-0136 International: 1-412-317-0459 About PacBio PacBio (NASDAQ:...

April 16, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Seq...

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples New extraction-to-library prep workflow enables highly accurate long-read sequencing from archived clinical samples, expanding opportunities in cancer research MENLO PARK, Calif. and WOBURN, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample preparation technologies, today announced a joint workflow has been developed for robust HiFi sequencing o...

April 15, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gen...

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics MENLO PARK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected PacBio HiFi sequencing on the Revio® system to generate large-scale environmental and host-associated meta...

March 18, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Announces the Appointment of Chris Gibson to the Board of Direc...

PacBio Announces the Appointment of Chris Gibson to the Board of Directors Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (NASDAQ: RXRX), a clinical-stage biot...

March 5, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Da...

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research Collaboration powers secure international data sharing through the HiFi Solves Global Consortium MENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowi...

February 24, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch